Locust Wood Capital Advisers’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-211,643
| Closed | -$7.89M | – | 32 |
|
|
2022
Q2 | $7.89M | Buy |
+211,643
| New | +$7.89M | 0.49% | 32 |
|
|
2022
Q1 | – | Sell |
-2,074,647
| Closed | -$88.1M | – | 32 |
|
|
2021
Q4 | $88.1M | Buy |
2,074,647
+512,706
| +33% | +$21.8M | 4.4% | 2 |
|
|
2021
Q3 | $67.8M | Sell |
1,561,941
-148,093
| -9% | -$6.43M | 3.68% | 5 |
|
|
2021
Q2 | $73.1M | Buy |
1,710,034
+1,452
| +0.1% | +$62.1K | 4.21% | 4 |
|
|
2021
Q1 | $66M | Sell |
1,708,582
-33,948
| -2% | -$1.31M | 3.88% | 4 |
|
|
2020
Q4 | $62.6M | Buy |
1,742,530
+597,795
| +52% | +$21.5M | 3.57% | 4 |
|
|
2020
Q3 | $43.7M | Buy |
1,144,735
+84,855
| +8% | +$3.24M | 2.82% | 11 |
|
|
2020
Q2 | $37.2M | Buy |
+1,059,880
| New | +$37.2M | 2.31% | 13 |
|